#Artificial Intelligence in Pharma
Explore articles tagged with Artificial Intelligence in Pharma
One System for Both Sides of Pharma
HRV Pharma's RIKO is designed to bridge the gap between pharmaceutical manufacturers and customers. Drawing on millions of proprietary decisions across 55 countries, the AI-native platform supports faster partner qualification, transparent enquiry matching and early risk assessment across the pharmaceutical value chain.
RIKO by the Numbers
Millennium Newsroom highlights the reported results of RIKO, HRV Pharma's AI-native pharmaceutical operating system. From 94% predictive accuracy in early nitrosamine risk assessments to 85% faster supplier qualification and commercial enquiry screening in under two seconds, RIKO applies pharmaceutical decision intelligence to real business challenges.
Meet RIKO, Built From Seven Years of Pharma Decisions
HRV Pharma has launched RIKO, an AI-native pharmaceutical operating system built on more than seven years of industry decisions. Drawing on insights from a network of 50+ FDA and EU GMP certified partners and customers across 55 countries, RIKO brings together AI-driven reasoning to support pharmaceutical sourcing, risk assessment and supplier qualification.